BOSTON, March 7, 2011 - Through various presentations to be delivered at the Drug Information Association (DIA) 23rd Annual EuroMeeting, being held March 28-30, 2011 in Geneva, Switzerland, experts from PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, will address advanced approaches to help the biopharmaceutical industry meet demands of a changing global marketplace.
Experts from PAREXEL will be available at Stands 1050, 1052, 1151, and 1153 in the exhibit hall to discuss how the Company can help biopharmaceutical companies improve early-stage decisions, accelerate pivotal trials, reach new markets, and leverage technologies for increased operational quality and efficiency. PAREXEL experts will discuss new operational models, supported by technology, to help its clients achieve greater benefits and speed development.
The DIA EuroMeeting program features the following presentations by PAREXEL experts, which address the benefits of combined clinical and technology expertise to enable more effective information flow and improved data access for greater visibility into trials - and ultimately, better decision making:
Tuesday, March 29
o Session 1, 9:00: Use of Electronic Health Records for Clinical Research,
Isabelle de Zegher, Worldwide Senior Director Technology Integration and
Wednesday, March 30
o Session 5, 9:00: How to Go Effectively from Data Collection in CDASH to
Submission in SDTM: The need for an eCRF library, Isabelle de Zegher,
Worldwide Senior Director Technology Integration & Data Standards
o Session 6, 11:00: Using Technology to Improve the Clinical Trial
Process, Liz Love, Product Manager
o Session 8, 16:00: Simplicity (for sites) is the Ultimate Sophistication,
Nikki Dowlman, Product Director
"Key Regulatory and Market Access Considerations: Gaining the Right Perspective for Regional and Global Development and Commercialization," which has a focus on the Asia/Pacific region, will provide insights to assist biopharmaceutical companies with strategic approaches to product development and commercialization, as well as to demonstrate product value to patients, payers, and providers, particularly in emerging high growth markets.
"Knowledge Management Enablers - Operational and Quality Control Centres," to be presented by Siegfried Schmitt, Ph.D., Principal Consultant, in Session 8 on Wednesday, March 30 at 16:00, will reinforce key Quality by Design (QbD) concepts. Dr. Schmitt will provide timely background and practical advice as regulators move forward on joint QbD pilot reviews and increase efforts toward regional harmonization.
For more information about PAREXEL visit www.PAREXEL.com or Stands 1050, 1052, 1151, and 1153 during the meeting. Information about the 23rd Annual DIA EuroMeeting can be found at www.diahome.org.
About PAREXEL International
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 52 countries around the world, and has approximately 10,380 employees. For more information about PAREXEL International visit www.PAREXEL.com.
SOURCE PAREXEL International Corporation
CONTACT: Jennifer Baird, Senior Director of Public Relations, PAREXEL International, +1-781-434-4409, Jennifer.Baird@PAREXEL.com; Kim Baker or Gene Carozza, PAN Communications, +1-978-474-1900, PAREXEL@pancomm.com
Web Site: www.parexel.com